Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference
Authors:
- Shahid AhmedShahid Ahmed
- Nicholas BosmaNBNicholas Bosma
- Michael MoserMMMichael Moser
- Shahida AhmedSAShahida Ahmed
- Bryan BrunetBBBryan Brunet
- Janine DaviesJDJanine Davies
- Corinne DollCDCorinne Doll
- Dorie-Anna DueckDDDorie-Anna Dueck
- Christina A. KimCKChristina A. Kim
- Shuying JiSJShuying Ji
- Duc LeDLDuc Le
- Richard Lee-YingRLRichard Lee-Ying
Open Access
- 8 March 2022
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 29 (3) , 1796-1807
Abstract
The Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) convened virtually on 4 November 2021. The WCGCCC is an interactive multi-disciplinary conference attended by health care professionals, including surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals from across four Western Canadian provinces, British Columbia, Alberta, Saskatchewan, and Manitoba, who are involved in the care of patients with gastrointestinal cancer. They participated in presentation and discussion sessions for the purpose of developing recommendations on the role of systemic therapy and its optimal sequence in patients with resectable metastatic colorectal cancer.Keywords
This publication has 59 references indexed in Scilit:
- Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trialsBMC Cancer, 2010
- Predicting High Grade Lesions of Sinusoidal Obstruction Syndrome Related to Oxaliplatin-Based Chemotherapy for Colorectal Liver MetastasesAnnals of Surgery, 2010
- Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver MetastasesAnnals of Surgical Oncology, 2009
- Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver MetastasisAnnals of Surgery, 2009
- A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancerAnnals of Oncology, 2009
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Safe liver resection following chemotherapy for colorectal metastases is a matter of timingBritish Journal of Cancer, 2007
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Neoadjuvant Chemotherapy for Metastatic Colon Cancer: A Cautionary NoteJournal of Clinical Oncology, 2005
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004